{"url":"https://lda.senate.gov/api/v1/filings/cdcc95da-750f-4e4c-b605-dfb446c2d054/","filing_uuid":"cdcc95da-750f-4e4c-b605-dfb446c2d054","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2010,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/cdcc95da-750f-4e4c-b605-dfb446c2d054/print/","filing_document_content_type":"text/html","income":"45000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Stephen M. Ryan, Partner","dt_posted":"2011-01-18T21:18:46.800000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"600 13th Street NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":24338,"url":"https://lda.senate.gov/api/v1/registrants/24338/","house_registrant_id":31445,"name":"MCDERMOTT WILL & SCHULTE LLP","description":"Law Firm","address_1":"500 North Capitol Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ERIC ZIMMERMAN","contact_telephone":"+1 202-204-1457","dt_updated":"2026-07-28T15:49:17.474570-04:00"},"client":{"id":131899,"url":"https://lda.senate.gov/api/v1/clients/131899/","client_id":1005433,"name":"ISIS PHARMACEUTICALS","general_description":"pharmaceutical research company","client_government_entity":false,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-03-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":40292,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M","last_name":"RYAN","suffix":null,"suffix_display":null},"covered_position":"Deputy Counsel, President's Commission on","new":false},{"lobbyist":{"id":46579,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"DUANE","last_name":"RANSOM","suffix":null,"suffix_display":null},"covered_position":"Member)","new":false},{"lobbyist":{"id":46474,"prefix":null,"prefix_display":null,"first_name":"SHEILA","nickname":null,"middle_name":"D","last_name":"WALCOFF","suffix":null,"suffix_display":null},"covered_position":"Representatives","new":false},{"lobbyist":{"id":41606,"prefix":null,"prefix_display":null,"first_name":"KAREN","nickname":null,"middle_name":null,"last_name":"SEALANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":40292,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M","last_name":"RYAN","suffix":null,"suffix_display":null},"covered_position":"Organized Crime.","new":false},{"lobbyist":{"id":46579,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"DUANE","last_name":"RANSOM","suffix":null,"suffix_display":null},"covered_position":"Member).","new":false},{"lobbyist":{"id":46474,"prefix":null,"prefix_display":null,"first_name":"SHEILA","nickname":null,"middle_name":"D","last_name":"WALCOFF","suffix":null,"suffix_display":null},"covered_position":"Representatives.","new":false},{"lobbyist":{"id":41606,"prefix":null,"prefix_display":null,"first_name":"KAREN","nickname":null,"middle_name":null,"last_name":"SEALANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":40292,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M","last_name":"RYAN","suffix":null,"suffix_display":null},"covered_position":"Organized Crime.","new":false},{"lobbyist":{"id":46579,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"DUANE","last_name":"RANSOM","suffix":null,"suffix_display":null},"covered_position":"Member).","new":false},{"lobbyist":{"id":46474,"prefix":null,"prefix_display":null,"first_name":"SHEILA","nickname":null,"middle_name":"D","last_name":"WALCOFF","suffix":null,"suffix_display":null},"covered_position":"Representatives.","new":false},{"lobbyist":{"id":41606,"prefix":null,"prefix_display":null,"first_name":"KAREN","nickname":null,"middle_name":null,"last_name":"SEALANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}